Evidence map›Paper›PMID 25071194›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Elimination of damaged mitochondria through mitophagy reduces mitochondrial oxidative stress and increases tolerance to trichothecenes.

Mohamed Anwar Bin-Umer, John E McLaughlin, Matthew S Butterly, Susan McCormick, Nilgun E Tumer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Yeast mitophagy: Unanswered questions.Biochimica et biophysica acta. General subjects · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.Oxidative medicine and cellular longevity · 2019
    Review
  19. Review
  20. Modulators of Redox Metabolism in Head and Neck Cancer.Antioxidants & redox signaling · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohamed Anwar Bin-UmerDepartment of Plant Biology and Pathology, School of Environmental and Biological Sciences, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901; and.
John E McLaughlinDepartment of Plant Biology and Pathology, School of Environmental and Biological Sciences, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901; and.
Matthew S ButterlyDepartment of Plant Biology and Pathology, School of Environmental and Biological Sciences, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901; and.
Susan McCormickBacterial Foodborne Pathogens and Mycology Unit, National Center for Agricultural Utilization Research, Agricultural Research Service, US Department of Agriculture, Peoria, IL 61604.
Nilgun E TumerDepartment of Plant Biology and Pathology, School of Environmental and Biological Sciences, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901; and tumer@aesop.rutgers.edu.
Rutgers, The State University of New Jersey · USNational Center for Agricultural Utilization Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichothecene mycotoxins are natural contaminants of small grain cereals and are encountered in the environment, posing a worldwide threat to human and animal health. Their mechanism of toxicity is poorly understood, and little is known about cellular protection mechanisms against trichothecenes. We previously identified inhibition of mitochondrial protein synthesis as a novel mechanism for trichothecene-induced cell death. To identify cellular functions involved in trichothecene resistance, we screened the Saccharomyces cerevisiae deletion library for increased sensitivity to nonlethal concentrations of trichothecin (Tcin) and identified 121 strains exhibiting higher sensitivity than the parental strain. The largest group of sensitive strains had significantly higher reactive oxygen species (ROS) levels relative to the parental strain. A dose-dependent increase in ROS levels was observed in the parental strain treated with different trichothecenes, but not in a petite version of the parental strain or in the presence of a mitochondrial membrane uncoupler, indicating that mitochondria are the main site of ROS production due to toxin exposure. Cytotoxicity of trichothecenes was alleviated after treatment of the parental strain and highly sensitive mutants with antioxidants, suggesting that oxidative stress contributes to trichothecene sensitivity. Cotreatment with rapamycin and trichothecenes reduced ROS levels and cytotoxicity in the parental strain relative to the trichothecene treatment alone, but not in mitophagy deficient mutants, suggesting that elimination of trichothecene-damaged mitochondria by mitophagy improves cell survival. These results reveal that increased mitophagy is a cellular protection mechanism against trichothecene-induced mitochondrial oxidative stress and a potential target for trichothecene resistance.

Indexed as

AnimalsDrug Resistance, FungalFood ContaminationFood SafetyGene Knockout TechniquesGenes, FungalHumansMitochondriaMitophagyOxidative StressReactive Oxygen SpeciesSaccharomyces cerevisiaeSirolimusTrichothecenesReactive Oxygen SpeciesSirolimusTrichothecenesdeoxynivalenolFusarium graminearumFusarium head blight

Identifiers

PMID25071194
PMCPMC4136610
OpenAlexW1966978656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.